See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2023_Ayala_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 25,759,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 110,000 |
| 2 | PropertyPlantAndEquipmentNet | 38,000 |
| 3 | remainder_Assets | 23,000 |
| 4 | LiabilitiesCurrent | 2,303,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,891,000 |
| 9 | ResearchAndDevelopmentExpense | 7,616,000 |
| 10 | remainder_Expenses | 3,103,000 |
| 11 | remainder_Revenues | 250,000 |
| 12 | remainder_NetIncome | 5,001,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,930,000 |
| 1 | Liabilities | 2,303,000 |
| 2 | Expenses | 19,610,000 |
| 3 | Revenues | 250,000 |
| 4 | StockholdersEquity | 23,627,000 |
| 5 | NetIncome | -14,359,000 |
| 6 | ComprehensiveNetIncome | -14,359,000 |
| 7 | BaseVar | 26,547,000 |
| 8 | EconomicCapitalRatio | 1.86 |
Edgar->Model Mapping
Feature Distribution
Change over Time
